-+ 0.00%
-+ 0.00%
-+ 0.00%

KAILERA THERAPEUTICS - HRS-7535 LOWERS HBA1C BY 1.5%-1.68% IN PHASE 3 TYPE 2 DIABETES TRIAL

Reuters·07/07/2026 11:00:04

Please log in to view news